×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INAB – in8bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INAB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
08:35 am
inab
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager [Yahoo! Finance]
High
Report
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager [Yahoo! Finance]
12/19
08:00 am
inab
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
High
Report
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
11/6
04:28 pm
inab
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
Medium
Report
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
11/6
04:00 pm
inab
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Medium
Report
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights
10/29
08:00 am
inab
IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
Medium
Report
IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
10/27
08:00 am
inab
IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications
High
Report
IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications
10/16
06:38 am
inab
IN8bio (NASDAQ:INAB) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Medium
Report
IN8bio (NASDAQ:INAB) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
10/13
10:59 am
inab
IN8bio (NASDAQ:INAB) was given a new $4.00 price target on by analysts at Mizuho.
Low
Report
IN8bio (NASDAQ:INAB) was given a new $4.00 price target on by analysts at Mizuho.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/22
05:15 pm
inab
Form SCHEDULE 13G IN8BIO, INC. Filed by: Stonepine Capital Management, LLC
Medium
Report
Form SCHEDULE 13G IN8BIO, INC. Filed by: Stonepine Capital Management, LLC
12/19
05:23 pm
inab
Form 8-K IN8BIO, INC. For: Dec 18
High
Report
Form 8-K IN8BIO, INC. For: Dec 18
11/24
11:16 am
inab
Form 8-K IN8BIO, INC. For: Nov 21
Medium
Report
Form 8-K IN8BIO, INC. For: Nov 21
11/6
04:03 pm
inab
Form 10-Q IN8BIO, INC. For: Sep 30
Medium
Report
Form 10-Q IN8BIO, INC. For: Sep 30
11/6
04:02 pm
inab
Form 8-K IN8BIO, INC. For: Nov 06
High
Report
Form 8-K IN8BIO, INC. For: Nov 06
10/27
08:01 am
inab
Form 8-K IN8BIO, INC. For: Oct 27
High
Report
Form 8-K IN8BIO, INC. For: Oct 27
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: